Ron Finklestien

Exploring Castor Maritime’s Recent Moves in the Shipping Industry ...

Castor Maritime Inc. CTRM experienced a notable surge on Friday following the announcement of an agreement to divest M/V Magic Venus, a 2010-built...

Restoration of Tennessee’s Copper Basin Mining District Revitalizing Tennessee’s Copper Basin Mining District: A Story of Transformation and Regeneration

Since the late 1800s, Tennessee's Copper Basin mining district has been a site of extensive environmental degradation caused by mining, processing, and chemical manufacturing operations. Over the years, tens of millions of cubic yards of soil and waste...

Reasons Why ManpowerGroup (MAN) Stock Should Be Held...

ManpowerGroup Inc. has shown a 6.3% appreciation in its shares over the past three months, accompanied by an impressive Growth Score of B. This robust style...

Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales

Financial News: Crude Oil Surges, Constellation Brands Reports Downbeat Sales Market Update U.S. stocks traded higher...

Allogene Therapeutics Shakes up Strategy: Bold Move, Says Expert Allogene Therapeutics...

Allogene Therapeutics Inc ALLO has announced a significant strategic shift, deprioritizing the currently enrolling third-line Phase 2 ALPHA2 and EXPAND trials...

The Mysterious Signal in Today’s Jobs Report The Mysterious Signal in Today’s Jobs Report

A stronger-than-expected December rise in nonfarm payrolls dominated the headlines this morning. But the markets reacted more to an indicator that rarely gets...

The Inner Workings of Proprietary Trading Firms

Prop trading firms, also known as proprietary trading firms, maneuver through the intricate pathways of the financial sector, navigating complex financial strategies to garner profits directly from market activity. Unlike...

Struggles and Triumphs in the Stock Market: Applied Therapeutics Takes a Hit While Other Companies Soar

The news of Applied Therapeutics, Inc.'s fall from grace hit the stock market like a bolt of lightning on a clear day. The company released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients...